These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35260045)

  • 21. Nanodelivery of doxorubicin for age-related macular degeneration.
    Kelly SJ; Halasz K; Smalling R; Sutariya V
    Drug Dev Ind Pharm; 2019 May; 45(5):715-723. PubMed ID: 30704311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity.
    Al-Fatlawi INAA; Pouresmaeil V; Davoodi-Dehaghani F; Pouresmaeil A; Akhtari A; Tabrizi MH
    BMC Biotechnol; 2024 Apr; 24(1):18. PubMed ID: 38600497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
    Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
    Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles.
    Ding Z; Chen W; Jiang F; Mo M; Bi Y; Kong F
    Food Res Int; 2023 Jan; 163():112141. PubMed ID: 36596096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis Folate-linked Chitosan-coated Quetiapine/BSA Nano-Carriers as the Efficient Targeted Anti-Cancer Drug Delivery System.
    Al-Hasnawi HNG; Pouresmaeil V; Davoodi-Dehaghani F; Rahban S; Pouresmaeil A; Homayouni Tabrizi M
    Mol Biotechnol; 2024 Sep; 66(9):2297-2307. PubMed ID: 37633875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour-specific hybrid nanoparticles in therapy of breast cancer.
    Kilicay E; Erdal E; Elci P; Hazer B; Denkbas EB
    J Microencapsul; 2024 Jan; 41(1):45-65. PubMed ID: 38095892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabrication of bovine serum albumin-polyethylene glycol nanoparticle conjugated-folic acid loaded-naringenin as an efficient carrier biomacromolecule for suppression of cancer cells.
    Firouzabadi K; Karimi E; Tabrizi MH
    Biotechnol Appl Biochem; 2023 Apr; 70(2):790-797. PubMed ID: 36059122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
    Badran MM; Mady MM; Ghannam MM; Shakeel F
    Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles.
    Şenel B; Öztürk AA
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1835-1848. PubMed ID: 31491363
    [No Abstract]   [Full Text] [Related]  

  • 35. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
    Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
    AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
    Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
    Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-proliferative activity of chitosan-coated oxypeucedanin nano-chitosomes (COPD-NCs) against human HT-29 colon cancer cells: in vitro study.
    Almohammed MAO; Meshkani S; Homayouni Tabrizi M; Sharbatiyan M; Nasiraei Haghighi H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2133-2143. PubMed ID: 37787784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.